Can a new drug delay Alzheimer's in people with a genetic mutation?
NCT ID NCT06384573
First seen Nov 12, 2025 · Last updated May 13, 2026 · Updated 20 times
Summary
This study tests the drug lecanemab in 40 people who have a genetic form of Alzheimer's disease. The goal is to see if removing amyloid plaques from the brain can delay the start of symptoms or slow the disease. Participants previously received another anti-amyloid drug and will now receive lecanemab to see if it can fully clear plaques and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
-
Neuroscience Research Australia
Randwick, New South Wales, 2031, Australia
-
The National Hospital for Neurology and Neurosurgery
London, Greater London, WC1B 3BG, United Kingdom
-
University of Alabama in Birmingham
Birmingham, Alabama, 35294, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.